Search
for
Sort by
Research 901–930 of 1000+
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- RETRACTED: Genetic association between asthma and alopecia areata: A two‐sample Mendelian randomization study
- Real-world evidence in alopecia areata treatment: A narrative review
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- BH29 Psychological distress in alopecia areata: are we doing enough?
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Deuruxolitinib for Alopecia Areata.
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- 165 Single-cell RNA sequencing analysis unveils highly active yet diminished CD14+CD16- circulating monocytes, independent of alopecia areata severity
- 229 Single cell transcriptomics identifies a potential role for Arg1+ macrophages in alopecia areata pathogenesis
- Excimer Laser: A Module of the Alopecia Areata Common Protocol
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- 097 LFA-1 blockade prevents the onset of alopecia areata in C3H/HeJ mice
- Treating Alopecia Areata: Current Practices Versus New Directions
- Oral Lichen Planus
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- RETRACTED: Explore the genetic exposure to alopecia areata
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED
- National, Regional, and Global Epidemiology of Alopecia Areata: A Systematic Analysis Based on Modeling Study
- Role of janus kinase inhibitors in the treatment of alopecia areata
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients